We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




How to Proceed after Abnormal Pap Results

By HospiMedica staff writers
Posted on 30 May 2002
New guidelines designed to help clinicians decide how to manage women whose Pap tests are abnormal were published in the April 24, 2002, issue of the Journal of the American Medical Association (JAMA).

The new guidelines describe how best to utilize new technologies, including liquid-based cytology and DNA testing for human papillomavirus (HPV), the primary cause of cervical cancer. More...
One of the most important recommendations addresses women with the most common type of abnormal Pap test, called ASCUS, or atypical squamous cells of undetermined significance. Prior to these guidelines, women with ASCUS would have either several repeat Pap tests or undergo a colposcopy. The new guidelines say other approaches may still be used, but HPV testing is preferred whenever liquid-based Pap tests are employed. If the liquid test is used, the laboratory can test the same sample used for the original Pap test for HPV, eliminating the need for a repeat doctor visit.

The test can reassure women who are HPV negative that they are unlikely to have cervical cancer, while identifying those women who are HPV positive and in need for further evaluation. For women with more serious abnormalities on their Pap test, the guidelines recommend colposcopy and find HPV testing has no role. This is an important change in recommended practice. The American Society for Colposcopy and Cervical Pathology (ASCCP) sponsored the guidelines, working with representatives from 29 national organizations and federal agencies involved in women's health care.

JAMA is making the Consensus Guidelines available at no charge on the Internet (www.ama-assn.org).




Related Links:
Consensus Guidelines

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Pediatric Mask
Respire SOFT
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new, inexpensive stick-on sweat sensor measures lipid levels, offering a noninvasive way to continuously monitor cholesterol and triglycerides. (Image Credit: California Institute of Technology)

Wearable Patch Enables Continuous Noninvasive Cholesterol and Triglyceride Monitoring

Cholesterol and triglyceride testing typically relies on phlebotomy and intermittent lipid panels, limiting real-time assessment of cardiovascular and metabolic risk. Noninvasive monitoring could reduce... Read more

Surgical Techniques

view channel
Image: Phasix Mesh is a fully resorbable monofilament scaffold designed for rapid tissue incorporation, combining synthetic mesh repair strength with biologic graft-like remodeling. (Photo courtesy of BD)

Resorbable Mesh Evaluated to Prevent Incisional Hernias After Abdominal Surgery

Incisional hernia is a common complication after abdominal surgery and can necessitate additional interventions and prolonged recovery. Preventive strategies remain limited, and there are currently no... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.